Pediatric Allergy Treatments Face Significant Insurance Hurdles, Study Finds
New research indicates that insurance delays and denials frequently prevent children from accessing essential biologic medications for severe asthma and allergies.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Insurance approval for pediatric biologics can take a month or longer.
- A significant portion of prescriptions for severe allergies and asthma are denied by insurers.
- The study analyzed 326 prescriptions for children with an average age of 11 between 2018 and 2026.
A new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting has revealed that administrative barriers are significantly hindering access to pediatric treatments. Researchers found that insurance companies often delay or outright reject coverage for biologic therapies, even when specialist physicians determine they are necessary for a child's health.
Biologics are a class of injectable medications that target specific parts of the immune system responsible for allergic diseases. These treatments are typically prescribed for children suffering from severe eczema, chronic hives, food allergies, or asthma that does not improve with standard therapies. However, obtaining these drugs requires a process known as prior authorization, where insurers must approve the prescription before covering the cost.
The investigation tracked 326 biologic prescriptions issued at a children's hospital between 2018 and 2026. The patients involved had an average age of 11 years. According to findings published in the Annals of Allergy Asthma & Immunology, the approval process can often stretch beyond a month, and many requests are ultimately denied by insurance providers.
Dr. Aarti Pandya, a co-author of the study and ACAAI member, noted that these delays occur after a medical professional has already decided on the best course of action. She emphasized that forcing families to wait weeks for medication can put children at risk of developing serious, avoidable health complications. The research team is calling for a more streamlined and rapid approval system to better serve pediatric patients.
What to know: This research was based on data from a single hospital system and may reflect specific regional insurance challenges. Always consult with a qualified medical professional to navigate treatment options and insurance requirements for chronic conditions.
Source Medical Xpress — medicalxpress.com/news/2026-11-delays-denials-kids-dont-allergy.html ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …